The global fluoroscopy systems/equipment market size was estimated at 3.05 billion in 2016 and is expected to grow at a CAGR of 5.1% during the forecast period. The market is predominantly driven by rising number of interventional radiology procedures that demand real-time imaging such as that in fluoroscopy.
According to a research published in NCBI, usage of CT fluoroscopy in interventional radiology procedures have led to a remarkable decrease in procedure time and radiation dose as well as radiation-associated risks in comparison with conventional CT guidance procedures. The aforementioned benefits are likely to increase the adoption of these devices over the coming years.
U.S. fluoroscopy systems market by product, 2014 - 2025 (USD Million)
This equipment is consistently being used in a wide range of interventional radiological procedures, especially in the treatment of conditions such as varicose veins, Peripheral Artery Disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other prevalent medical conditions. This consistent usage is anticipated to impel fluoroscopy systems market growth potential in the future.
In addition, increasing number of orthopedic surgeries & angiography as a consequence of sports injuries and a growing geriatric population base is believed to be high impact rendering drivers. Hand-held fluoroscopes are gaining popularity in emergency facilities and on-site settings due to their capacity to perform efficient real-time injury assessment in athletes. The advent of fluoroscopes in sports medicine is also predicted to be a result of associated benefits, such as high cost-efficiency and portability.
Technological advancements such as integration with image intensifiers such as Flat-Panel Detector (FPD), rotational angiography with Computed Tomography (CT) images, and usage of thallium-doped cesium iodide coupled with magnifying fluoroscopes are expected to accelerate market growth further over the coming years. Consequentially, benefits such as high image quality, reduced radiation risks, time & workflow efficiency, dose reduction, minimal invasion & trauma, and higher visibility during surgical procedures are expected to drive physician preference, thereby, boosting the penetration of these devices throughout the forecast period
Fluoroscopy devices held the largest share of over 69.0% in the product segment in 2016. The dominant share captured by this segment is believed to be a consequence of usage in wide array of procedures such as image-guided biopsy, angiography, and discography. In addition, increasing usage of fluoroscopes in previously unexplored applications such as quality assurance and non-destructive testing of medical devices is expected to be a key factor contributing to the substantial share of this segment.
Associated benefits with fluoroscopy devices such as high portability, radiation sensitivity, X-ray recording capability optical magnification, and lower levels of scattered radiation are responsible for it emerging as the dominant segment. Furthermore, fluoroscopy devices are relatively less affected by body surfaces, resulting in greater clarity, stability, and real-time tracking of images.
Technically advanced fluoroscopes, which are equipped with radiation reduction instruments and control circuits, developed for interventional angiography suites and cardiac catheterization laboratories are known to provide automatic dose rate and image quality control logic. The aforementioned factors are expected to be some of the key factors accentuating demand over the years.
Integration of fluoroscopes with advanced image intensifiers and spectral shaping filter technology is believed to optimize the image-guided surgical procedures, thereby increasing their adoption by radiologists and surgeons. Furthermore, advent of digitalized fluoroscopy systems that are used in gastroenterology is presumed to be responsible for their emergence as the largest product segment in 2016.
The cardiovascular segment held the largest share in 2016, as a consequence of increasing prevalence of cardiovascular diseases, which is predicted to bolster the demand for highly efficient diagnostic imaging tools. In addition, high demand for this equipment in cardiovascular imaging due to the appropriate intensity of its energy projections has widened the scope for growth over the previous years.
The procedures most frequently performed with fluoroscopy include percutaneous coronary interventions, coronary angiography, diagnostic electrophysiology studies, and radiographic catheter ablation. Rising number of conferences and exhibitions by manufacturing companies to promote fluoroscopy instruments in cardiology is also a key contributing factor to the segment growth.
The orthopedics segment is expected to exhibit constant growth during the forecast period. This can be attributed to high adoption of fluoroscopy devices and C-arms in orthopedic clinics, critical care, urgent care clinics, and imaging centers. The unprecedented shift in patient demographics and rising geriatric & obese population suffering from movement problems are also high impact rendering drivers for this segment.
These conditions upsurge the demand for fluoroscopy equipment, especially in case of hip & joint replacements and fractures. Fluoroscopy equipment is continuously required in orthopedic trauma surgeries, kyphoplasty, vertebroplasty, pelvic fixation, deformity correction, and CT-guided biopsies. These aforementioned factors are anticipated to present the segment with high growth potential.
Hospitals accounted for the largest share in the end-use segment in 2016, which can be attributed to the high patient turnaround volume and frequent readmissions. Supportive infrastructure facilitates successful surgical procedures, which mandates the adoption of C-arms and fluoroscopy devices, thus, resulting in a higher share of hospitals.
The increasing number of government initiatives aimed at promoting efficient treatment facilities to generate quick results and improve overall healthcare efficiency also served as key contributing growth factors. For instance, an initiative undertaken by the U.S. FDA to reduce and optimize radiation exposure of medical imaging has resulted in improved treatment of various conditions and greater safety in hospitals. These factors cumulatively are responsible for hospitals capturing larger share in the end-use segment.
Global fluoroscopy equipment market share by end-use, 2016 (%)
The increasing inclination of public & private healthcare organizations to promote advanced imaging & radiographic instruments, with better patient outcomes, serves as one of the key factors responsible for the substantial share of the segment. Furthermore, currently, hospitals are increasingly using fully automated systems that possess the ability to detect disease conditions at early stages.
Diagnostic centers are presumed to witness constant growth throughout the forecast period. This can be attributed to the rising importance of anatomy visualization in emergency medicine. Fluoroscopy facilitates early detection when used in conjunction with other therapeutic and diagnostic media, such as contrast agents. For instance, during cardiac catheterization, fluoroscopy devices serve as an adjunct to evaluate the blood flow and detect the presence of arterial blockages.
North America accounted for the largest share in the fluoroscopy equipment market in 2016. Consistent number of strategic collaborations aimed at development of new generation of products is responsible for the substantial share. Enforcement of stringent regulatory and reimbursement framework striving to ensure patient safety & high diagnostic standards are anticipated to propel the demand in this region.
The substantial share registered by North America is attributed to growing base of obese population. The growing number of minimally invasive surgeries have resulted in the substantial share. The greater adoption of these devices, in the region, over the past years, is an efficient aid that provides enhanced guidance in minimally invasive surgeries.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period. Emerging economies in the region, such as India and China, are witnessing strong economic growth. Growing prevalence of disease and improving infrastructural standards have spurred the demand for advanced diagnostics across this region.
The global market is highly competitive in nature. This competition is marked by implementation of sustainability strategies by prominent companies such as GE Healthcare, Philips Healthcare, and Siemens Healthineers, which account for their dominant market share. These companies focus on various strategies such as geographical expansion, new product development initiatives, and mergers & acquisitions.
In August 2015, GE Healthcare entered into a 7-year collaborative agreement with Temple University Health System to expand radiology-based services. This initiative was also undertaken to address challenges pertaining to market competition, cost control, patient outcomes, and reimbursement framework in medical imaging.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
The U.S., Canada, Germany, The U.K., Japan, China, India, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global fluoroscopy systems market on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Application Outlook (Revenue, USD Million, 2014 - 2025)
Pain Management & Trauma
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.